Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials
Top Cited Papers
- 31 May 2004
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 50 (5), 714-721
- https://doi.org/10.1016/j.jaad.2003.12.010
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Epidemiology of solar keratosesBritish Journal of Dermatology, 2006
- A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.Archives of Dermatology, 2002
- Clinical effect of imiquimod 5% cream in the treatment of actinic keratosisJournal of the American Academy of Dermatology, 2002
- Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trialJournal of the American Academy of Dermatology, 2002
- Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six casesBritish Journal of Dermatology, 2001
- The nature of solar keratosis: A critical review in historical perspectiveJournal of the American Academy of Dermatology, 2000
- Clinical presentation of actinic keratoses and squamous cell carcinomaJournal of the American Academy of Dermatology, 2000
- The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia)British Journal of Dermatology, 1998
- Thinning of the ozone layer: Facts and consequencesJournal of the American Academy of Dermatology, 1992
- Health Effects of Sunlight Exposure in the United StatesArchives of Dermatology, 1988